CRISPR Therapeutics AG
CRSP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$106 | -$209 | -$136 | -$37 |
| Dep. & Amort. | $4 | $5 | $5 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $17 | $18 | $20 | $22 |
| Change in WC | $11 | -$17 | $55 | -$24 |
| Other Non-Cash | -$10 | $89 | $2 | -$15 |
| Operating Cash Flow | -$85 | -$114 | -$54 | -$50 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$334 | -$215 | -$206 | -$267 |
| Inv. Sales/Matur. | $215 | $310 | $186 | $373 |
| Other Inv. Act. | $0 | -$25 | $0 | $0 |
| Investing Cash Flow | -$119 | $70 | -$20 | $106 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $278 | $2 | $9 | $15 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $19 | $0 | $2 | $2 |
| Financing Cash Flow | $297 | $2 | $11 | $17 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $93 | -$42 | -$63 | $73 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $205 | $239 | $310 | $237 |
| End Cash | $298 | $197 | $247 | $310 |
| Free Cash Flow | -$85 | -$114 | -$54 | -$50 |